跳至主要内容
临床试验/NL-OMON53334
NL-OMON53334招募中2 期

SGM-101 tumor-targeted fluorescence endoscopy to enable discrimination of malignant from benign tissue in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia: a feasibility study - SGM-T1

eids Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • 1. Patient must have suspected HGD/T1RC and scheduled for a local endoscopic
  • en-bloc resection. The rectum is defined as the area between the linea dentata
  • and 10cm ab ano.
  • 2. Age > 18 years old
  • 3. Patients should be capable and willing to give signed informed consent
  • before study specific procedures.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study
  • 1. Prior participation in this study
  • 2. Previous administration of SGM-101
  • 3. Patients with a history of anaphylactic shock
  • 4. Patients pregnant or breastfeeding, lack of effective contraception in male
  • or female patients with reproductive potential
  • 5. Any condition that the investigator considers to be potentially jeopardizing
  • the patients* well-being or the study objectives.

研究者

相似试验

SGM-101 tumor-targeted fluorescence endoscopy to... | 临床试验